Berry Global (BERY) 10-Q 4 May 23 2023 Q2 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares shares in Millions	6 Months Ended
	Apr. 01, 2023	May 04, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Period End Date	Apr. 01, 2023
Current Fiscal Year End Date	--10-01
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Document Transition Report	false
Entity File Number	001-35672
Entity Registrant Name	BERRY GLOBAL GROUP, INC.
Entity Central Index Key	0001378992
Entity Incorporation, State or Country Code	DE
Entity Address, Address Line One	101 Oakley Street
Entity Address, City or Town	Evansville
Entity Address, State or Province	IN
Entity Address, Postal Zip Code	47710
City Area Code	812
Local Phone Number	424-2904
Entity Tax Identification Number	20-5234618
Title of 12(b) Security	Common Stock, $0.01 par value per share
Trading Symbol	BERY
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		119.2

Consolidated Statements of Inco

Consolidated Statements of Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Consolidated Statements of Income [Abstract]
Net sales	$ 3,288	$ 3,775	$ 6,348	$ 7,348
Costs and expenses:
Cost of goods sold	2,682	3,154	5,224	6,192
Selling, general and administrative	220	207	456	442
Amortization of intangibles	60	65	120	133
Restructuring and transaction activities	25	8	37	11
Operating income	301	341	511	570
Other expense	1	6	2	6
Interest expense	79	71	150	142
Income before income taxes	221	264	359	422
Income tax expense	47	59	79	96
Net income	$ 174	$ 205	$ 280	$ 326
Net income per share:
Basic (in dollars per share)	$ 1.44	$ 1.53	$ 2.29	$ 2.42
Diluted (in dollars per share)	$ 1.42	$ 1.5	$ 2.27	$ 2.36

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Consolidated Statements of Comprehensive Income [Abstract]
Net income	$ 174	$ 205	$ 280	$ 326
Other comprehensive income, net of tax:
Currency translation	60	37	201	15
Derivative instruments	(31)	71	(32)	100
Other comprehensive income	29	108	169	115
Comprehensive income	$ 203	$ 313	$ 449	$ 441

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Millions	Apr. 01, 2023	Oct. 01, 2022
Current assets:
Cash and cash equivalents	$ 696	$ 1,410
Accounts receivable	1,751	1,777
Finished goods	1,128	1,010
Raw materials and supplies	736	792
Prepaid expenses and other current assets	220	175
Total current assets	4,531	5,164
Noncurrent assets:
Property, plant and equipment	4,612	4,342
Goodwill and intangible assets	6,866	6,685
Right-of-use assets	507	521
Other assets	97	244
Total assets	16,613	16,956
Current liabilities:
Accounts payable	1,350	1,795
Accrued employee costs	243	253
Other current liabilities	715	783
Current portion of long-term debt	12	13
Total current liabilities	2,320	2,844
Noncurrent liabilities:
Long-term debt	9,295	9,242
Deferred income taxes	575	707
Employee benefit obligations	162	160
Operating lease liabilities	414	429
Other long-term liabilities	552	378
Total liabilities	13,318	13,760
Stockholders' equity:
Common stock (119.2 and 124.2 million shares issued, respectively)	1	1
Additional paid-in capital	1,214	1,177
Retained earnings	2,314	2,421
Accumulated other comprehensive loss	(234)	(403)
Total stockholders' equity	3,295	3,196
Total liabilities and stockholders' equity	$ 16,613	$ 16,956

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - shares shares in Millions	Apr. 01, 2023	Oct. 01, 2022
Stockholders' equity:
Common stock, shares issued (in shares)	119.2	124.2

Consolidated Statements of Cash

Consolidated Statements of Cash Flows - USD ($) $ in Millions	6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Cash Flows from Operating Activities:
Net income	$ 280	$ 326
Adjustments to reconcile net cash from operating activities:
Depreciation	279	284
Amortization of intangibles	120	133
Non-cash interest (income) expense, net	(27)	8
Settlement of derivatives	36	0
Deferred income tax	(51)	(43)
Share-based compensation expense	30	28
Other non-cash operating activities, net	8	(14)
Changes in working capital	(495)	(714)
Changes in other assets and liabilities	(12)	(22)
Net cash from operating activities	168	(14)
Cash Flows from Investing Activities:
Additions to property, plant and equipment, net	(385)	(367)
Acquisition of a business and other	(88)	3
Net cash from investing activities	(473)	(364)
Cash Flows from Financing Activities:
Proceeds from long-term borrowings	500	244
Repayments on long-term borrowings	(583)	(9)
Proceeds from issuance of common stock	18	22
Repurchase of common stock	(333)	(351)
Dividends paid	(65)	0
Other, net	11	0
Net cash from financing activities	(452)	(94)
Effect of currency translation on cash	43	3
Net change in cash and cash equivalents	(714)	(469)
Cash and cash equivalents at beginning of period	1,410	1,091
Cash and cash equivalents at end of period	$ 696	$ 622

Consolidated Statements of Chan

Consolidated Statements of Changes in Stockholders' Equity - USD ($) $ in Millions	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Other Comprehensive Loss [Member]	Retained Earnings [Member]	Total
Balance at Oct. 02, 2021	$ 1	$ 1,134	$ (296)	$ 2,341	$ 3,180
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	0	0	0	326	326
Other comprehensive income	0	0	115	0	115
Share-based compensation	0	28	0	0	28
Proceeds from issuance of common stock	0	22	0	0	22
Common stock repurchased and retired	0	(10)	0	(341)	(351)
Balance at Apr. 02, 2022	1	1,174	(181)	2,326	3,320
Balance at Jan. 01, 2022	1	1,170	(289)	2,412	3,294
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	0	0	0	205	205
Other comprehensive income	0	0	108	0	108
Share-based compensation	0	7	0	0	7
Proceeds from issuance of common stock	0	6	0	0	6
Common stock repurchased and retired	0	(9)	0	(291)	(300)
Balance at Apr. 02, 2022	1	1,174	(181)	2,326	3,320
Balance at Oct. 01, 2022	1	1,177	(403)	2,421	3,196
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	0	0	0	280	280
Other comprehensive income	0	0	169	0	169
Share-based compensation	0	30	0	0	30
Proceeds from issuance of common stock	0	18	0	0	18
Common stock repurchased and retired	0	(11)	0	(322)	(333)
Dividends paid	0	0	0	(65)	(65)
Balance at Apr. 01, 2023	1	1,214	(234)	2,314	3,295
Balance at Dec. 31, 2022	1	1,199	(263)	2,322	3,259
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	0	0	0	174	174
Other comprehensive income	0	0	29	0	29
Share-based compensation	0	7	0	0	7
Proceeds from issuance of common stock	0	13	0	0	13
Common stock repurchased and retired	0	(5)	0	(150)	(155)
Dividends paid	0	0	0	(32)	(32)
Balance at Apr. 01, 2023	$ 1	$ 1,214	$ (234)	$ 2,314	$ 3,295

Basis of Presentation

Basis of Presentation	6 Months Ended
	Apr. 01, 2023
Basis of Presentation [Abstract]
Basis of Presentation	1. Basis of Presentation The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. (“the Company,” “we,” or “Berry”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") for interim reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements . In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates. In the opinion of management, all adjustments (consisting of normal recurring adjustments) considered necessary for a fair presentation have been included, and all subsequent events up to the time of the filing have been evaluated. For further information, refer to the Company’s most recent Form 10-K filed with the SEC.

Critical Accounting Policies an

Critical Accounting Policies and Recent Accounting Pronouncements	6 Months Ended
	Apr. 01, 2023
Critical Accounting Policies and Recent Accounting Pronouncements [Abstract]
Critical Accounting Policies and Recent Accounting Pronouncements	2. Critical Accounting Policies and Recent Accounting Pronouncements There have been no material changes in critical accounting policies from those described in our most recent Form 10-K. Reference Rate Reform In 2020, the FASB issued ASU 2020-04, Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting (Topic 848). This standard provides temporary optional expedients and exceptions to the GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as SOFR. In 2022, the FASB issued ASU 2022-06, which deferred the sunset date of Topic 848 to December 31, 2024. The Company is evaluating timing of adoption, but does not expect a material change to our consolidated financial statements or disclosures.

Revenue and Accounts Receivable

Revenue and Accounts Receivable	6 Months Ended
	Apr. 01, 2023
Revenue and Accounts Receivable [Abstract]
Revenue	3. Revenue and Accounts Receivable Our revenues are primarily derived from the sale of non-woven, flexible and rigid products to customers. Revenue is recognized when performance obligations are satisfied, in an amount reflecting the consideration to which the Company expects to be entitled. We consider the promise to transfer products to be our sole performance obligation. If the consideration agreed to in a contract includes a variable amount, we estimate the amount of c onsideration we expect to be entitled to in exchange for transferring the promised goods to the customer using the most likely amount method. Our main source of variable consideration is customer rebates. There are no material instances where variable consideration is constrained and not recorded at the initial time of sale. Generally, our revenue is recognized at a point in time for standard promised goods at the time of shipment, when title and risk of loss pass to the customer. The
Accounts Receivable	Accounts receivable are presented net of allowance for credit losses of $18 million and $18 million at April 1, 2023 and October 1, 2022, respectively. The Company records its current expected credit losses based on a variety of factors including historical loss experience and current customer financial condition. The changes to our current expected credit losses, write-off activity, and recoveries were not material for any of the periods presented. The Company has entered into various factoring agreements, including customer-based supply chain financing programs, to sell certain receivables to third-party financial institutions. Agreements which result in true sales of the transferred receivables, which occur when receivables are transferred without recourse to the Company, are reflected as a reduction of accounts receivable on the consolidated balance sheets and the proceeds are included in the cash flows from operating activities in the consolidated statements of cash flows. The fees associated with the transfer of receivables for all programs were not material for any of the periods presented.

Acquisition

Acquisition	6 Months Ended
	Apr. 01, 2023
Acquisition [Abstract]
Acquisition	4. Acquisition Pro-Western Plastics In March 2023, the Company acquired Pro-Western Plastics Ltd. (“Pro-Western”), a leading plastics injection molding company, for a purchase price of $88 million. The acquired business will be operated within the Consumer Packaging North America segment. To finance the purchase, the Company used existing liquidity. The acquisition has been accounted for under the purchase method of accounting and accordingly, the purchase price has been allocated to the identifiable assets and liabilities based on preliminary values at the acquisition date. The Company has recognized $35 million of goodwill on this transaction primarily as a result of expected cost synergies and expects goodwill to be deductible for tax purposes.

Restructuring and Transaction A

Restructuring and Transaction Activities	6 Months Ended
	Apr. 01, 2023
Restructuring and Transaction Activities [Abstract]
Restructuring and Transaction Activities	5. Restructuring and Transaction Activities The table below includes the significant components of our restructuring and transaction activities, by reporting segment: Quarterly Period Ended Two Quarterly Periods Ended April 1, 2023 April 2, 2022 April 1, 2023 April 2, 2022 Consumer Packaging International $ 12 $ 5 $ 15 $ 7 Consumer Packaging North America 7 2 8 3 Health, Hygiene & Specialties 5 — 8 (1 ) Engineered Materials 1 1 6 2 Consolidated $ 25 $ 8 $ 37 $ 11 The table below sets forth the activity with respect to the restructuring and transaction activities accrual at April 1, 2023: Restructuring Employee Severance and Benefits Facility Exit Costs Non-cash Impairment Charges Transaction Activities Total Balance as of October 1, 2022 $ 2 $ 3 $ — $ — $ 5 Charges 16 8 4 9 37 Non-cash items — — (4 ) — (4 ) Cash (5 ) (9 ) — (9 ) (23 ) Balance as of April 1, 2023 $ 13 $ 2 $ — $ — $ 15

Leases

Leases	6 Months Ended
	Apr. 01, 2023
Leases [Abstract]
Leases	6. Leases The Company leases certain manufacturing facilities, warehouses, office space, manufacturing equipment, office equipment, and automobiles. Supplemental lease information is as follows: Leases Classification April 1, 2023 October 1, 2022 Operating leases: Operating lease right-of-use assets Right-of-use assets $ 507 $ 521 Current operating lease liabilities Other current liabilities 109 108 Noncurrent operating lease liabilities Operating lease liability 414 429 Finance leases: Finance lease right-of-use assets Property, plant, and equipment, net $ 34 $ 38 Current finance lease liability Current portion of long-term debt 9 9 Noncurrent finance lease liabilities Long-term debt, less current portion 21 24

Long-Term Debt

Long-Term Debt	6 Months Ended
	Apr. 01, 2023
Long-Term Debt [Abstract]
Long-Term Debt	7. Long-Term Debt Long-term debt consists of the following: Facility Maturity Date April 1, 2023 October 1, 2022 Term loan (a) July 2026 $ 3,390 3,440 Revolving line of credit May 2024 — — 0.95 (b) February 2024 279 800 1.00 (c) July 2025 761 686 1.57 January 2026 1,525 1,525 4.875 July 2026 1,250 1,250 1.65 January 2027 400 400 1.50 (c) July 2027 408 367 5.50 April 2028 500 — 4.50 February 2026 291 298 5.625 July 2027 500 500 Debt discounts and deferred fees (42 ) (60 ) Finance leases and other Various 45 49 Total long-term debt 9,307 9,255 Current portion of long-term debt (12 ) (13 ) Long-term debt, less current portion $ 9,295 9,242 (a) Effectively 80% fixed interest rate with interest rate swaps (see Note 8). (b) Indicates debt which has been classified as long-term debt in accordance with the Company's ability and intention to refinance such obligations on a long-term basis. (c) Euro denominated During the quarter ended April 1, 2023, the Company issued $500 million aggregate principal amount of 5.50% first priority senior secured notes due 2028. The proceeds were used to repurchase a portion of the Company’s 0.95% first priority senior secured notes due 2024. Debt discounts and deferred financing fees are presented net of Long-term debt, less the current portion on the Consolidated Balance Sheets and are amortized to Interest expense, net on the Consolidated Statements of Income through maturity.

Financial Instruments and Fair

Financial Instruments and Fair Value Measurements	6 Months Ended
	Apr. 01, 2023
Financial Instruments and Fair Value Measurements [Abstract]
Financial Instruments and Fair Value Measurements	8. Financial Instruments and Fair Value Measurements In the normal course of business, the Company is exposed to certain risks arising from business operations and economic factors. The Company may use derivative financial instruments to help manage market risk and reduce the exposure to fluctuations in interest rates and foreign currencies. These financial instruments are not used for trading or other speculative purposes. Cross-Currency Swaps The Company is party to certain cross-currency swaps to hedge a portion of our foreign currency risk. The swap agreements mature June 2024 (€1,625 million) and July 2027 (£700 million). In addition to cross-currency swaps, we hedge a portion of our foreign currency risk by designating foreign currency denominated long-term debt as net investment hedges of certain foreign operations. As of April 1, 2023, we had outstanding long-term debt of €785 million that was designated as a hedge of our net investment in certain euro-denominated foreign subsidiaries. When valuing cross-currency swaps the Company utilizes Level 2 inputs (substantially observable). Interest Rate Swaps The primary purpose of the Company’s interest rate swap activities is to manage interest expense variability associated with our outstanding variable rate term loan debt. When valuing interest rate swaps the Company utilizes Level 2 inputs (substantially observable). During fiscal 2023, the Company elected to cash settle existing interest rate swaps and received net proceeds of $36 million. The offset is included in Accumulated other comprehensive loss and is being amortized to Interest expense through the term of the original swaps. Following the settlement, the Company entered into interest rate swaps with matching notional amounts with expiration in June 2026. As of April 1, 2023, the Company effectively had (i) a $450 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 4.128%, (ii) a $400 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 4.522%, (iii) a $473 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 3.961%, (iv) an $884 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 4.522%, and (v) a $500 million interest rate swap transaction that swaps a one-month variable LIBOR contract for a fixed annual rate of 3.672%. The Company's interest rate swap transactions all expire in June 2026. The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows: Derivative Instruments Hedge Designation Balance Sheet Location April 1, 2023 October 1, 2022 Cross-currency swaps Designated Other assets $ — $ 147 Cross-currency swaps Designated Other long-term liabilities 125 — Interest rate swaps Designated Other assets 1 11 Interest rate swaps Designated Other long-term liabilities 39 3 Interest rate swaps Not designated Other long-term liabilities 113 117 The effect of the Company’s derivative instruments on the Consolidated Statements of Income is as follows: Quarterly Period Ended Two Quarterly Periods Ended Derivative Instruments Statements of Income Location April 1, 2023 April 2, 2022 April 1, 2023 April 2, 2022 Cross-currency swaps Interest expense $ (10 ) $ (4 ) $ (21 ) $ (7 ) Interest rate swaps Interest expense (11 ) 12 (17 ) 24 Non-recurring Fair Value Measurements The Company has certain assets that are measured at fair value on a non-recurring basis when impairment indicators are present or when the Company completes an acquisition. The Company adjusts certain long-lived assets to fair value only when the carrying values exceed the fair values. The categorization of the framework used to value the assets is considered Level 3, due to the subjective nature of the unobservable inputs used to determine the fair value. These assets that are subject to our annual impairment analysis primarily include our definite lived and indefinite lived intangible assets, including Goodwill and our property, plant and equipment. The Company reviews Goodwill and other indefinite lived assets for impairment as of the first day of the fourth fiscal quarter each year and more frequently if impairment indicators exist. The Company determined Goodwill and other indefinite lived assets were not impaired in our annual fiscal 2022 assessment. No impairment indicators were identified in the current quarter. Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of April 1, 2023 and October 1, 2022, along with the impairment loss recognized on the fair value measurement during the period: As of April 1, 2023 Level 1 Level 2 Level 3 Total Impairment Indefinite-lived trademarks $ — $ — $ 248 $ 248 $ — Goodwill — — 5,032 5,032 — Definite lived intangible assets — — 1,586 1,586 — Property, plant, and equipment — — 4,612 4,612 4 Total $ — $ — $ 11,478 $ 11,478 $ 4 As of October 1, 2022 Level 1 Level 2 Level 3 Total Impairment Indefinite-lived trademarks $ — $ — $ 247 $ 247 $ — Goodwill — — 4,832 4,832 — Definite lived intangible assets — — 1,606 1,606 — Property, plant, and equipment — — 4,342 4,342 — Total $ — $ — $ 11,027 $ 11,027 $ — The Company’s financial instruments consist primarily of cash and cash equivalents, long-term debt, interest rate and cross-currency swap agreements, and finance lease obligations. The of our marketable long-term indebtedness exceeded by $ million as of . The Company’s long-term debt fair values were determined using Level 2 inputs (substantially observable).

Income Taxes

Income Taxes	6 Months Ended
	Apr. 01, 2023
Income Taxes [Abstract]
Income Taxes	9. Income Taxes On a year-to-date comparison to the statutory rate, the higher effective tax rate was negatively impacted by state taxes and global intangible low-taxed income provisions, partially offset by other discrete items.

Segment and Geographic Data

Segment and Geographic Data	6 Months Ended
	Apr. 01, 2023
Segment and Geographic Data [Abstract]
Segment and Geographic Data	10. Segment and Geographic Data The Company’s operations are organized into four reporting segments: Consumer Packaging International, Consumer Packaging North America, Health, Hygiene & Specialties, and Engineered Materials. The structure is designed to align us with our customers, provide optimal service, drive future growth, and to facilitate synergies realization. Selected information by reportable segment is presented in the following tables: Quarterly Period Ended Two Quarterly Periods Ended April 1, 2023 April 2, 2022 April 1, 2023 April 2, 2022 Net sales: Consumer Packaging International $ 1,059 $ 1,139 $ 1,995 $ 2,195 Consumer Packaging North America 774 880 1,537 1,732 Health, Hygiene & Specialties 677 822 1,340 1,640 Engineered Materials 778 934 1,476 1,781 Total net sales $ 3,288 $ 3,775 $ 6,348 $ 7,348 Operating income: Consumer Packaging International $ 75 $ 97 $ 121 $ 166 Consumer Packaging North America 93 85 164 131 Health, Hygiene & Specialties 34 69 68 131 Engineered Materials 99 90 158 142 Total operating income $ 301 $ 341 $ 511 $ 570 Depreciation and amortization: Consumer Packaging International $ 77 $ 82 $ 151 $ 164 Consumer Packaging North America 54 53 105 107 Health, Hygiene & Specialties 44 44 88 89 Engineered Materials 25 27 55 57 Total depreciation and amortization $ 200 $ 206 $ 399 $ 417 Selected information by geographical region is presented in the following tables: Quarterly Period Ended Two Quarterly Periods Ended April 1, 2023 April 2, 2022 April 1, 2023 April 2, 2022 Net sales: United States and Canada $ 1,751 $ 1,996 $ 3,447 $ 3,948 Europe 1,237 1,399 2,286 2,616 Rest of world 300 380 615 784 Total net sales $ 3,288 $ 3,775 $ 6,348 $ 7,348

Contingencies and Commitments

Contingencies and Commitments	6 Months Ended
	Apr. 01, 2023
Contingencies and Commitments [Abstract]
Contingencies and Commitments	11. Contingencies and Commitments The Company is party to various legal proceedings involving routine claims which are incidental to its business. Although the Company’s legal and financial liability with respect to such proceedings cannot be estimated with certainty, we believe that any ultimate liability would not be material to our financial position, results of operations or cash flows. The Company has various purchase commitments for raw materials, supplies, and property and equipment incidental to the ordinary conduct of business.

Basic and Diluted Earnings Per

Basic and Diluted Earnings Per Share	6 Months Ended
	Apr. 01, 2023
Basic and Diluted Earnings Per Share [Abstract]
Basic and Diluted Earnings Per Share	12. Basic and Diluted Earnings Per Share Basic net income or earnings per share ("EPS") is calculated by dividing the net income attributable to common stockholders by the weighted-average number of common shares outstanding during the period, without consideration for common stock equivalents. Diluted EPS includes the effects of options and restricted stock units, if dilutive. The following tables provide a reconciliation of the numerator and denominator of the basic and diluted EPS calculations: Quarterly Period Ended Two Quarterly Periods Ended (in millions, except per share amounts) April 1, 2023 April 2, 2022 April 1, 2023 April 2, 2022 Numerator Consolidated net income $ 174 $ 205 $ 280 $ 326 Denominator Weighted average common shares outstanding - basic 120.7 133.8 122.2 134.6 Dilutive shares 1.8 3.1 1.1 3.4 Weighted average common and common equivalent shares outstanding - diluted 122.5 136.9 123.3 138.0 Per common share earnings Basic $ 1.44 $ 1.53 $ 2.29 $ 2.42 Diluted $ 1.42 $ 1.50 $ 2.27 $ 2.36 1.2 million and 2.6 million shares were excluded from the diluted EPS calculation for the quarterly and two quarterly periods ended April 1, 2023 as their effect would be anti-dilutive. 1.2 million and 1.3 million shares were excluded for the quarterly and two quarterly periods ended April 2, 2022.

Accumulated Other Comprehensive

Accumulated Other Comprehensive Loss	6 Months Ended
	Apr. 01, 2023
Accumulated Other Comprehensive Loss [Abstract]
Accumulated Other Comprehensive Loss	13. Accumulated Other Comprehensive Loss The components and activity of Accumulated other comprehensive loss are as follows: Quarterly Period Ended Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at December 31, 2022 $ (314 ) $ (32 ) $ 83 $ (263 ) Other comprehensive income (loss) before reclassifications 60 — (21 ) 39 Net amount reclassified — — (10 ) (10 ) Balance at April 1, 2023 $ (254 ) $ (32 ) $ 52 $ (234 ) Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at January 1, 2022 $ (176 ) $ (67 ) $ (46 ) $ (289 ) Other comprehensive income (loss) before reclassifications 37 — 69 106 Net amount reclassified — — 2 2 Balance at April 2, 2022 $ (139 ) $ (67 ) $ 25 $ (181 ) Two Quarterly Periods Ended Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at October 1, 2022 $ (455 ) $ (32 ) $ 84 $ (403 ) Other comprehensive income (loss) before reclassifications 201 — (16 ) 185 Net amount reclassified — — (16 ) (16 ) Balance at April 1, 2023 $ (254 ) $ (32 ) $ 52 $ (234 ) Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at October 2, 2021 $ (154 ) $ (67 ) $ (75 ) $ (296 ) Other comprehensive income (loss) before reclassifications 15 — 95 110 Net amount reclassified — — 5 5 Balance at April 2, 2022 $ (139 ) $ (67 ) $ 25 $ (181 )

Basis of Presentation (Policies

Basis of Presentation (Policies)	6 Months Ended
	Apr. 01, 2023
Basis of Presentation [Abstract]
Basis of Presentation	The accompanying unaudited Condensed Consolidated Financial Statements of Berry Global Group, Inc. (“the Company,” “we,” or “Berry”) have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) pursuant to the rules and regulations of the Securities and Exchange Commission (the "SEC") for interim reporting. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements
Use of Estimates	In preparing financial statements in conformity with GAAP, we must make estimates and assumptions that affect the reported amounts and disclosures at the date of the financial statements and during the reporting period. Actual results could differ from those estimates.

Critical Accounting Policies _2

Critical Accounting Policies and Recent Accounting Pronouncements (Policies)	6 Months Ended
	Apr. 01, 2023
Critical Accounting Policies and Recent Accounting Pronouncements [Abstract]
Recent Accounting Pronouncements	Reference Rate Reform In 2020, the FASB issued ASU 2020-04, Reference Rate Reform - Facilitation of the Effects of Reference Rate Reform on Financial Reporting (Topic 848). This standard provides temporary optional expedients and exceptions to the GAAP guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from LIBOR and other interbank offered rates to alternative reference rates, such as SOFR. In 2022, the FASB issued ASU 2022-06, which deferred the sunset date of Topic 848 to December 31, 2024. The Company is evaluating timing of adoption, but does not expect a material change to our consolidated financial statements or disclosures.

Restructuring and Transaction_2

Restructuring and Transaction Activities (Tables)	6 Months Ended
	Apr. 01, 2023
Restructuring and Transaction Activities [Abstract]
Restructuring and Transaction Activity Charges	The table below includes the significant components of our restructuring and transaction activities, by reporting segment: Quarterly Period Ended Two Quarterly Periods Ended April 1, 2023 April 2, 2022 April 1, 2023 April 2, 2022 Consumer Packaging International $ 12 $ 5 $ 15 $ 7 Consumer Packaging North America 7 2 8 3 Health, Hygiene & Specialties 5 — 8 (1 ) Engineered Materials 1 1 6 2 Consolidated $ 25 $ 8 $ 37 $ 11
Restructuring Accrual Activity	The table below sets forth the activity with respect to the restructuring and transaction activities accrual at April 1, 2023: Restructuring Employee Severance and Benefits Facility Exit Costs Non-cash Impairment Charges Transaction Activities Total Balance as of October 1, 2022 $ 2 $ 3 $ — $ — $ 5 Charges 16 8 4 9 37 Non-cash items — — (4 ) — (4 ) Cash (5 ) (9 ) — (9 ) (23 ) Balance as of April 1, 2023 $ 13 $ 2 $ — $ — $ 15

Leases (Tables)

Leases (Tables)	6 Months Ended
	Apr. 01, 2023
Leases [Abstract]
Lease Assets and Liabilities	Supplemental lease information is as follows: Leases Classification April 1, 2023 October 1, 2022 Operating leases: Operating lease right-of-use assets Right-of-use assets $ 507 $ 521 Current operating lease liabilities Other current liabilities 109 108 Noncurrent operating lease liabilities Operating lease liability 414 429 Finance leases: Finance lease right-of-use assets Property, plant, and equipment, net $ 34 $ 38 Current finance lease liability Current portion of long-term debt 9 9 Noncurrent finance lease liabilities Long-term debt, less current portion 21 24

Long-Term Debt (Tables)

Long-Term Debt (Tables)	6 Months Ended
	Apr. 01, 2023
Long-Term Debt [Abstract]
Long-Term Debt	Long-term debt consists of the following: Facility Maturity Date April 1, 2023 October 1, 2022 Term loan (a) July 2026 $ 3,390 3,440 Revolving line of credit May 2024 — — 0.95 (b) February 2024 279 800 1.00 (c) July 2025 761 686 1.57 January 2026 1,525 1,525 4.875 July 2026 1,250 1,250 1.65 January 2027 400 400 1.50 (c) July 2027 408 367 5.50 April 2028 500 — 4.50 February 2026 291 298 5.625 July 2027 500 500 Debt discounts and deferred fees (42 ) (60 ) Finance leases and other Various 45 49 Total long-term debt 9,307 9,255 Current portion of long-term debt (12 ) (13 ) Long-term debt, less current portion $ 9,295 9,242 (a) Effectively 80% fixed interest rate with interest rate swaps (see Note 8). (b) Indicates debt which has been classified as long-term debt in accordance with the Company's ability and intention to refinance such obligations on a long-term basis. (c) Euro denominated

Financial Instruments and Fai_2

Financial Instruments and Fair Value Measurements (Tables)	6 Months Ended
	Apr. 01, 2023
Financial Instruments and Fair Value Measurements [Abstract]
Fair Value of Derivatives and Location on Consolidated Balance Sheets	The Company records the fair value positions of all derivative financial instruments on a net basis by counterparty for which a master netting arrangement is utilized. Balances on a gross basis are as follows: Derivative Instruments Hedge Designation Balance Sheet Location April 1, 2023 October 1, 2022 Cross-currency swaps Designated Other assets $ — $ 147 Cross-currency swaps Designated Other long-term liabilities 125 — Interest rate swaps Designated Other assets 1 11 Interest rate swaps Designated Other long-term liabilities 39 3 Interest rate swaps Not designated Other long-term liabilities 113 117
Effect of Derivatives on Consolidated Statements of Income	The effect of the Company’s derivative instruments on the Consolidated Statements of Income is as follows: Quarterly Period Ended Two Quarterly Periods Ended Derivative Instruments Statements of Income Location April 1, 2023 April 2, 2022 April 1, 2023 April 2, 2022 Cross-currency swaps Interest expense $ (10 ) $ (4 ) $ (21 ) $ (7 ) Interest rate swaps Interest expense (11 ) 12 (17 ) 24
Assets Measured at Fair Value on Non-recurring Basis	Included in the following table are the major categories of assets measured at fair value on a non-recurring basis as of April 1, 2023 and October 1, 2022, along with the impairment loss recognized on the fair value measurement during the period: As of April 1, 2023 Level 1 Level 2 Level 3 Total Impairment Indefinite-lived trademarks $ — $ — $ 248 $ 248 $ — Goodwill — — 5,032 5,032 — Definite lived intangible assets — — 1,586 1,586 — Property, plant, and equipment — — 4,612 4,612 4 Total $ — $ — $ 11,478 $ 11,478 $ 4 As of October 1, 2022 Level 1 Level 2 Level 3 Total Impairment Indefinite-lived trademarks $ — $ — $ 247 $ 247 $ — Goodwill — — 4,832 4,832 — Definite lived intangible assets — — 1,606 1,606 — Property, plant, and equipment — — 4,342 4,342 — Total $ — $ — $ 11,027 $ 11,027 $ —

Segment and Geographic Data (Ta

Segment and Geographic Data (Tables)	6 Months Ended
	Apr. 01, 2023
Segment and Geographic Data [Abstract]
Selected Information by Reportable Segment	Selected information by reportable segment is presented in the following tables: Quarterly Period Ended Two Quarterly Periods Ended April 1, 2023 April 2, 2022 April 1, 2023 April 2, 2022 Net sales: Consumer Packaging International $ 1,059 $ 1,139 $ 1,995 $ 2,195 Consumer Packaging North America 774 880 1,537 1,732 Health, Hygiene & Specialties 677 822 1,340 1,640 Engineered Materials 778 934 1,476 1,781 Total net sales $ 3,288 $ 3,775 $ 6,348 $ 7,348 Operating income: Consumer Packaging International $ 75 $ 97 $ 121 $ 166 Consumer Packaging North America 93 85 164 131 Health, Hygiene & Specialties 34 69 68 131 Engineered Materials 99 90 158 142 Total operating income $ 301 $ 341 $ 511 $ 570 Depreciation and amortization: Consumer Packaging International $ 77 $ 82 $ 151 $ 164 Consumer Packaging North America 54 53 105 107 Health, Hygiene & Specialties 44 44 88 89 Engineered Materials 25 27 55 57 Total depreciation and amortization $ 200 $ 206 $ 399 $ 417
Selected Information by Geographical Region	Selected information by geographical region is presented in the following tables: Quarterly Period Ended Two Quarterly Periods Ended April 1, 2023 April 2, 2022 April 1, 2023 April 2, 2022 Net sales: United States and Canada $ 1,751 $ 1,996 $ 3,447 $ 3,948 Europe 1,237 1,399 2,286 2,616 Rest of world 300 380 615 784 Total net sales $ 3,288 $ 3,775 $ 6,348 $ 7,348

Basic and Diluted Earnings Pe_2

Basic and Diluted Earnings Per Share (Tables)	6 Months Ended
	Apr. 01, 2023
Basic and Diluted Earnings Per Share [Abstract]
Basic and Diluted Earnings Per Share	The following tables provide a reconciliation of the numerator and denominator of the basic and diluted EPS calculations: Quarterly Period Ended Two Quarterly Periods Ended (in millions, except per share amounts) April 1, 2023 April 2, 2022 April 1, 2023 April 2, 2022 Numerator Consolidated net income $ 174 $ 205 $ 280 $ 326 Denominator Weighted average common shares outstanding - basic 120.7 133.8 122.2 134.6 Dilutive shares 1.8 3.1 1.1 3.4 Weighted average common and common equivalent shares outstanding - diluted 122.5 136.9 123.3 138.0 Per common share earnings Basic $ 1.44 $ 1.53 $ 2.29 $ 2.42 Diluted $ 1.42 $ 1.50 $ 2.27 $ 2.36

Accumulated Other Comprehensi_2

Accumulated Other Comprehensive Loss (Tables)	6 Months Ended
	Apr. 01, 2023
Accumulated Other Comprehensive Loss [Abstract]
Accumulated Other Comprehensive Loss	The components and activity of Accumulated other comprehensive loss are as follows: Quarterly Period Ended Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at December 31, 2022 $ (314 ) $ (32 ) $ 83 $ (263 ) Other comprehensive income (loss) before reclassifications 60 — (21 ) 39 Net amount reclassified — — (10 ) (10 ) Balance at April 1, 2023 $ (254 ) $ (32 ) $ 52 $ (234 ) Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at January 1, 2022 $ (176 ) $ (67 ) $ (46 ) $ (289 ) Other comprehensive income (loss) before reclassifications 37 — 69 106 Net amount reclassified — — 2 2 Balance at April 2, 2022 $ (139 ) $ (67 ) $ 25 $ (181 ) Two Quarterly Periods Ended Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at October 1, 2022 $ (455 ) $ (32 ) $ 84 $ (403 ) Other comprehensive income (loss) before reclassifications 201 — (16 ) 185 Net amount reclassified — — (16 ) (16 ) Balance at April 1, 2023 $ (254 ) $ (32 ) $ 52 $ (234 ) Currency Translation Defined Benefit Pension and Retiree Health Benefit Plans Derivative Instruments Accumulated Other Comprehensive Loss Balance at October 2, 2021 $ (154 ) $ (67 ) $ (75 ) $ (296 ) Other comprehensive income (loss) before reclassifications 15 — 95 110 Net amount reclassified — — 5 5 Balance at April 2, 2022 $ (139 ) $ (67 ) $ 25 $ (181 )

Revenue and Accounts Receivab_2

Revenue and Accounts Receivable (Details) - USD ($) $ in Millions	Apr. 01, 2023	Oct. 01, 2022
Revenue and Accounts Receivable [Abstract]
Accrual for customer rebates	$ 95	$ 103
Allowance for credit losses	$ 18	$ 18

Acquisition (Details)

Acquisition (Details) - Pro-Western Plastics [Member] $ in Millions	1 Months Ended
	Mar. 31, 2023 USD ($)
Acquisition [Abstract]
Purchase price	$ 88
Goodwill	$ 35

Restructuring and Transaction_3

Restructuring and Transaction Activities, Restructuring Charges by Segment (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Restructuring Charges [Abstract]
Restructuring and transaction activities	$ 25	$ 8	$ 37	$ 11
Consumer Packaging International [Member]
Restructuring Charges [Abstract]
Restructuring and transaction activities	12	5	15	7
Consumer Packaging North America [Member]
Restructuring Charges [Abstract]
Restructuring and transaction activities	7	2	8	3
Health, Hygiene & Specialties [Member]
Restructuring Charges [Abstract]
Restructuring and transaction activities	5	0	8	(1)
Engineered Materials [Member]
Restructuring Charges [Abstract]
Restructuring and transaction activities	$ 1	$ 1	$ 6	$ 2

Restructuring and Transaction_4

Restructuring and Transaction Activities, Restructuring Accrual Activity (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Apr. 01, 2023	Oct. 01, 2022
Restructuring Accrual [Roll Forward]
Beginning balance	$ 5
Charges	37
Non-cash items	(4)	$ 0
Cash	(23)
Ending balance	15	5
Employee Severance and Benefits [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	2
Charges	16
Non-cash items	0
Cash	(5)
Ending balance	13	2
Facility Exit Costs [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	3
Charges	8
Non-cash items	0
Cash	(9)
Ending balance	2	3
Non-Cash Impairment Charges [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	0
Charges	4
Non-cash items	(4)
Cash	0
Ending balance	0	0
Transaction Activities [Member]
Restructuring Accrual [Roll Forward]
Beginning balance	0
Charges	9
Non-cash items	0
Cash	(9)
Ending balance	$ 0	$ 0

Leases (Details)

Leases (Details) - USD ($) $ in Millions	Apr. 01, 2023	Oct. 01, 2022
Operating Leases [Abstract]
Operating lease right-of-use assets	$ 507	$ 521
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Operating lease right-of-use assets	Operating lease right-of-use assets
Current operating lease liabilities	$ 109	$ 108
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Other current liabilities	Other current liabilities
Noncurrent operating lease liabilities	$ 414	$ 429
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Noncurrent operating lease liabilities	Noncurrent operating lease liabilities
Finance Leases [Abstract]
Finance lease right-of-use assets	$ 34	$ 38
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List]	Property, plant and equipment	Property, plant and equipment
Current finance lease liability	$ 9	$ 9
Finance Lease, Liability, Current, Statement of Financial Position [Extensible List]	Current portion of long-term debt	Current portion of long-term debt
Noncurrent finance lease liabilities	$ 21	$ 24
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Long-term debt	Long-term debt

Long-Term Debt (Details)

Long-Term Debt (Details) - USD ($) $ in Millions		6 Months Ended
		Apr. 01, 2023	Oct. 01, 2022
Long-term Debt [Abstract]
Debt discounts and deferred fees		$ (42)	$ (60)
Total long-term debt		9,307	9,255
Current portion of long-term debt		(12)	(13)
Long-term debt, less current portion		9,295	9,242
Term Loan [Member]
Long-term Debt [Abstract]
Long-term debt	[1]	$ 3,390	3,440
Maturity date		Jul. 31, 2026
Percentage of loan hedged with interest rate swaps to fix interest rate		80%
Revolving Line of Credit [Member]
Long-term Debt [Abstract]
Long-term debt		$ 0	0
Maturity date		May 31, 2024
0.95% First Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt	[2]	$ 279	800
Interest rate		0.95%
Maturity date		Feb. 29, 2024
1.00% First Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt	[3]	$ 761	686
Interest rate		1%
Maturity date		Jul. 31, 2025
1.57% First Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt		$ 1,525	1,525
Interest rate		1.57%
Maturity date		Jan. 31, 2026
4.875% First Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt		$ 1,250	1,250
Interest rate		4.875%
Maturity date		Jul. 31, 2026
1.65% First Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt		$ 400	400
Interest rate		1.65%
Maturity date		Jan. 31, 2027
1.50% First Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt	[3]	$ 408	367
Interest rate		1.50%
Maturity date		Jul. 31, 2027
5.50% First Priority Senior Secured Notes due April 2028 [Member]
Long-term Debt [Abstract]
Long-term debt		$ 500	0
Interest rate		5.50%
Maturity date		Apr. 30, 2028
Face amount of debt issued		$ 500
4.50% Second Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt		$ 291	298
Interest rate		4.50%
Maturity date		Feb. 28, 2026
5.625% Second Priority Senior Secured Notes [Member]
Long-term Debt [Abstract]
Long-term debt		$ 500	500
Interest rate		5.625%
Maturity date		Jul. 31, 2027
Finance Leases and Other [Member]
Long-term Debt [Abstract]
Long-term debt		$ 45	$ 49
[1]Effectively 80% fixed interest rate with interest rate swaps (see Note 8).[2] Indicates debt which has been classified as long-term debt in accordance with the Company's ability and intention to refinance such obligations on a long-term basis. Euro denominated

Financial Instruments and Fai_3

Financial Instruments and Fair Value Measurements, Cross-Currency Swaps (Details) - Apr. 01, 2023 € in Millions, £ in Millions	EUR (€)	GBP (£)
Euro Denominated [Member]
Cross-Currency Swaps [Abstract]
Long-term debt	€ 785
Cross-Currency Swap Maturing June 2024 [Member]
Cross-Currency Swaps [Abstract]
Notional amount of swap	€ 1,625
Cross-Currency Swap Maturing July 2027 [Member]
Cross-Currency Swaps [Abstract]
Notional amount of swap | £		£ 700

Financial Instruments and Fai_4

Financial Instruments and Fair Value Measurements, Interest Rate Swaps (Details) - USD ($) $ in Millions	6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022
Interest Rate Swaps [Abstract]
Settlement of derivatives	$ (36)	$ 0
Interest Rate Swaps [Member]
Interest Rate Swaps [Abstract]
Purpose of interest rate swap activities	The primary purpose of the Company’s interest rate swap activities is to manage interest expense variability associated with our outstanding variable rate term loan debt.
Settlement of derivatives	$ 36
Interest Rate Swap Expiring June 2026 [Member]
Interest Rate Swaps [Abstract]
Notional amount of swap	$ 450
Fixed annual rate of swap	4.128%
Interest Rate Swap Expiring June 2026 [Member] | LIBOR [Member]
Interest Rate Swaps [Abstract]
Term of variable rate	1 month
Interest Rate Swap Expiring June 2026 [Member]
Interest Rate Swaps [Abstract]
Notional amount of swap	$ 400
Fixed annual rate of swap	4.522%
Interest Rate Swap Expiring June 2026 [Member] | LIBOR [Member]
Interest Rate Swaps [Abstract]
Term of variable rate	1 month
Interest Rate Swap Expiring June 2026 [Member]
Interest Rate Swaps [Abstract]
Notional amount of swap	$ 473
Fixed annual rate of swap	3.961%
Interest Rate Swap Expiring June 2026 [Member] | LIBOR [Member]
Interest Rate Swaps [Abstract]
Term of variable rate	1 month
Interest Rate Swap Expiring June 2026 [Member]
Interest Rate Swaps [Abstract]
Notional amount of swap	$ 884
Fixed annual rate of swap	4.522%
Interest Rate Swap Expiring June 2026 [Member] | LIBOR [Member]
Interest Rate Swaps [Abstract]
Term of variable rate	1 month
Interest Rate Swap Expiring June 2026 [Member]
Interest Rate Swaps [Abstract]
Notional amount of swap	$ 500
Fixed annual rate of swap	3.672%
Interest Rate Swap Expiring June 2026 [Member] | LIBOR [Member]
Interest Rate Swaps [Abstract]
Term of variable rate	1 month

Financial Instruments and Fai_5

Financial Instruments and Fair Value Measurements, Fair Value of Derivative and Location on Consolidated Balance Sheets (Details) - USD ($) $ in Millions	Apr. 01, 2023	Oct. 01, 2022
Cross-Currency Swaps [Member] | Designated [Member] | Other Assets [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 0	$ 147
Cross-Currency Swaps [Member] | Designated [Member] | Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	125	0
Interest Rate Swaps [Member] | Designated [Member] | Other Assets [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	1	11
Interest Rate Swaps [Member] | Designated [Member] | Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	39	3
Interest Rate Swaps [Member] | Not Designated [Member] | Other Long-Term Liabilities [Member]
Derivative Instruments [Abstract]
Fair value of derivative instruments	$ 113	$ 117

Financial Instruments and Fai_6

Financial Instruments and Fair Value Measurements, Effect of Derivatives on Consolidated Statements of Income (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Cross-Currency Swaps [Member]
Derivative Instruments [Abstract]
Loss (gain) on derivative instruments	$ (10)	$ (4)	$ (21)	$ (7)
Loss (Gain) on Derivative Instruments, Statement of Income [Extensible Enumeration]	Interest Income (Expense), Nonoperating, Net	Interest Income (Expense), Nonoperating, Net	Interest Income (Expense), Nonoperating, Net	Interest Income (Expense), Nonoperating, Net
Interest Rate Swaps [Member]
Derivative Instruments [Abstract]
Loss (gain) on derivative instruments	$ (11)	$ 12	$ (17)	$ 24
Loss (Gain) on Derivative Instruments, Statement of Income [Extensible Enumeration]	Interest Income (Expense), Nonoperating, Net	Interest Income (Expense), Nonoperating, Net	Interest Income (Expense), Nonoperating, Net	Interest Income (Expense), Nonoperating, Net

Financial Instruments and Fai_7

Financial Instruments and Fair Value Measurements, Assets Measured at Fair Value on Non-Recurring Basis (Details) - USD ($) $ in Millions	6 Months Ended	12 Months Ended
	Apr. 01, 2023	Oct. 01, 2022
Impairment [Abstract]
Indefinite-lived trademarks	$ 0	$ 0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant, and equipment	4	0
Impairment charges	4	0
Fair Value Adjustment [Abstract]
Fair value of long-term indebtedness greater/(less) than book value	(336)
Fair Value on Non-Recurring Basis [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	247
Goodwill	5,032	4,832
Definite lived intangible assets	1,586	1,606
Property, plant, and equipment	4,612	4,342
Total	11,478	11,027
Fair Value on Non-Recurring Basis [Member] | Level 1 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant, and equipment	0	0
Total	0	0
Fair Value on Non-Recurring Basis [Member] | Level 2 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	0	0
Goodwill	0	0
Definite lived intangible assets	0	0
Property, plant, and equipment	0	0
Total	0	0
Fair Value on Non-Recurring Basis [Member] | Level 3 [Member]
Fair Value of Assets [Abstract]
Indefinite-lived trademarks	248	247
Goodwill	5,032	4,832
Definite lived intangible assets	1,586	1,606
Property, plant, and equipment	4,612	4,342
Total	$ 11,478	$ 11,027

Segment and Geographic Data, Se

Segment and Geographic Data, Selected Information by Reportable Segment (Details) $ in Millions	3 Months Ended		6 Months Ended
	Apr. 01, 2023 USD ($)	Apr. 02, 2022 USD ($)	Apr. 01, 2023 USD ($) Segment	Apr. 02, 2022 USD ($)
Segment and Geographic Data [Abstract]
Number of reporting segments | Segment			4
Selected Information by Reportable Segment [Abstract]
Net sales	$ 3,288	$ 3,775	$ 6,348	$ 7,348
Operating income	301	341	511	570
Depreciation and amortization	200	206	399	417
Operating Segment [Member] | Consumer Packaging International [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	1,059	1,139	1,995	2,195
Operating income	75	97	121	166
Depreciation and amortization	77	82	151	164
Operating Segment [Member] | Consumer Packaging North America [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	774	880	1,537	1,732
Operating income	93	85	164	131
Depreciation and amortization	54	53	105	107
Operating Segment [Member] | Health, Hygiene & Specialties [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	677	822	1,340	1,640
Operating income	34	69	68	131
Depreciation and amortization	44	44	88	89
Operating Segment [Member] | Engineered Materials [Member]
Selected Information by Reportable Segment [Abstract]
Net sales	778	934	1,476	1,781
Operating income	99	90	158	142
Depreciation and amortization	$ 25	$ 27	$ 55	$ 57

Segment and Geographic Data, _2

Segment and Geographic Data, Selected Information by Geographical Region (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Selected Information by Geographical Region [Abstract]
Net sales	$ 3,288	$ 3,775	$ 6,348	$ 7,348
Reportable Geographical Region [Member] | United States and Canada [Member]
Selected Information by Geographical Region [Abstract]
Net sales	1,751	1,996	3,447	3,948
Reportable Geographical Region [Member] | Europe [Member]
Selected Information by Geographical Region [Abstract]
Net sales	1,237	1,399	2,286	2,616
Reportable Geographical Region [Member] | Rest of World [Member]
Selected Information by Geographical Region [Abstract]
Net sales	$ 300	$ 380	$ 615	$ 784

Basic and Diluted Earnings Pe_3

Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Numerator [Abstract]
Consolidated net income	$ 174	$ 205	$ 280	$ 326
Denominator [Abstract]
Weighted average common shares outstanding - basic (in shares)	120.7	133.8	122.2	134.6
Dilutive shares (in shares)	1.8	3.1	1.1	3.4
Weighted average common and common equivalent shares outstanding - diluted (in shares)	122.5	136.9	123.3	138
Per Common Share Earnings [Abstract]
Basic (in dollars per share)	$ 1.44	$ 1.53	$ 2.29	$ 2.42
Diluted (in dollars per share)	$ 1.42	$ 1.5	$ 2.27	$ 2.36
Antidilutive Shares [Abstract]
Antidilutive shares excluded from computation of earnings per share (in shares)	1.2	1.2	2.6	1.3

Accumulated Other Comprehensi_3

Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended		6 Months Ended
	Apr. 01, 2023	Apr. 02, 2022	Apr. 01, 2023	Apr. 02, 2022
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance			$ 3,196
Other comprehensive income (loss) before reclassifications	$ 39	$ 106	185	$ 110
Net amount reclassified	(10)	2	(16)	5
Ending balance	3,295		3,295
Accumulated Other Comprehensive Loss [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(263)	(289)	(403)	(296)
Ending balance	(234)	(181)	(234)	(181)
Currency Translation [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(314)	(176)	(455)	(154)
Other comprehensive income (loss) before reclassifications	60	37	201	15
Net amount reclassified	0	0	0	0
Ending balance	(254)	(139)	(254)	(139)
Defined Benefit Pension and Retiree Health Benefit Plans [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	(32)	(67)	(32)	(67)
Other comprehensive income (loss) before reclassifications	0	0	0	0
Net amount reclassified	0	0	0	0
Ending balance	(32)	(67)	(32)	(67)
Derivative Instruments [Member]
Accumulated Other Comprehensive Loss [Roll Forward]
Beginning balance	83	(46)	84	(75)
Other comprehensive income (loss) before reclassifications	(21)	69	(16)	95
Net amount reclassified	(10)	2	(16)	5
Ending balance	$ 52	$ 25	$ 52	$ 25